Exploring the role of different neonatal nutrition regimens during the first week of life by urinary GC-MS metabolomics

International Journal of Molecular Sciences

Volumn 17, Issue 2, 2016, Pages

  Dessì, Angelica ^a   Murgia, Antonio ^a   Agostino, Rocco ^b   Pattumelli, Maria Grazia ^b   Schirru, Andrea ^a   Scano, Paola ^a   Fanos, Vassilios ^a   Caboni, Pierluigi ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b Internal Medicine Fatebenefratelli   (Italy)

Author keywords

AGA; Breastfeeding; Formula milk; Glycine; IUGR; LGA; Metabonomics; Myo inositol; Pseudouridine

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACONITIC ACID; ADIPIC ACID; ALANINE; ASPARTIC ACID; BENZOIC ACID; CITRIC ACID; GALACTOSE; GLUCOSE; GLYCERIC ACID; GLYCINE; HOMOSERINE; INOSITOL; OXALIC ACID; PHENYLALANINE; PSEUDOURIDINE; PYROGLUTAMIC ACID; SERINE; SUCCINIC ACID; THREONINE; XYLITOL;

ANTHROPOMETRIC PARAMETERS; ARTICLE; ARTIFICIAL MILK; BIRTH WEIGHT; BREAST FEEDING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE URINE LEVEL; HUMAN; INFANT NUTRITION; INTRAUTERINE GROWTH RETARDATION; LARGE FOR GESTATIONAL AGE; MALE; MASS FRAGMENTOGRAPHY; METABOLOMICS; NEWBORN; PHYSICAL CHEMISTRY; UPREGULATION; URINALYSIS; BOTTLE FEEDING; CHEMISTRY; OBESITY; PROCEDURES; URINE;

BOTTLE FEEDING; BREAST FEEDING; FETAL GROWTH RETARDATION; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; INFANT, NEWBORN; METABOLOMICS; OVERWEIGHT; URINE;

EID: 84975755277     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17020265     Document Type: Article

References (46)

1. Barker, D.J. Fetal origins of coronary heart disease. BMJ 1995, 311, 171-174. [CrossRef] [PubMed]
2. Dessì, A.; Puddu, M.; Ottonello, G.; Fanos, V. Metabolomics and fetal-neonatal nutrition: Between "not enough" and "too much". Molecules 2013, 18, 11724-11732. [CrossRef] [PubMed]
3. Hales, C.N.; Barker, D.J. Type 2 (non-insulin-dependent) diabetes mellitus: The thrifty phenotype hypothesis. Diabetologia 1992, 35, 595-601. [CrossRef] [PubMed]
4. Committee on Practice Bulletins Gynecology; American College of Obstetricians and Gynecologists. Intrauterine growth restriction. Clinical management guidelines for obstetrician-gynecologists. Int. J. Gynaecol. Obstet. 2001, 72, 85-96.
5. Nicholson, J.K.; Connelly, J.; Lindon, J.C.; Holmes, E. Metabonomics: A platform for studying drug toxicity and gene function. Nat. Rev. Drug Discov. 2002, 1, 153-161. [CrossRef] [PubMed]
6. Dessì, A.; Pravettoni, C.; Cesare Marincola, F.; Schirru, A.; Fanos, V. The biomarkers of fetal growth in intrauterine growth retardation and large for gestational age cases: From adipocytokines to a metabolomic all-in-one tool. Expert Rev. Proteom. 2015, 12, 309-316. [CrossRef] [PubMed]
7. Dessì, A.; Cesare Marincola, F.; Masili, A.; Gazzolo, D.; Fanos, V. Clinical metabolomics and nutrition: The new frontier in neonatology and pediatrics. BioMed Res. Int. 2014, 2014, 981219. [CrossRef] [PubMed]
8. Marincola, F.C.; Noto, A.; Caboni, P.; Reali, A.; Barberini, L.; Lussu, M.; Murgia, F.; Santoru, M.L.; Atzori, L.; Fanos, V. Metabolomic study of preterm human and formula milk by high resolution NMR and GC/MS analysis: Preliminary results. J. Matern. Fetal Neonatal Med. 2012, 25, 62-67. [CrossRef] [PubMed]
9. Dessì, A.; Atzori, L.; Noto, A.; Visser, G.H.A.; Gazzolo, D.; Zanardo, V.; Barberini, L.; Puddu, M.; Ottonello, G.; Atzei, A.; et al. Metabolomics in newborns with intrauterine growth retardation (IUGR): Urine reveals markers of metabolic syndrome. J. Matern. Fetal Neonatal Med. 2011, 2, 35-39. [CrossRef] [PubMed]
10. Horgan, R.P.; Broadhurst, D.I.; Dunn,W.B.; Brown, M.; Heazell, A.E.P.; Kell, D.B.; Baker, P.N.; Kenny, L.C. Changes in the metabolic footprint of placental explant-conditioned medium cultured in different oxygen tensions from placentas of small for gestational age and normal pregnancies. Placenta 2010, 31, 893-901. [CrossRef] [PubMed]
11. Logan, K.M.;Wijeyesekera, A.D.; Perez, I.G.; Hyde, M.J.; Romero, M.G.; Jeffries, S.; Andreas, N.; Gale, C.; Holmes, E.; Modi, N. Infants of Mothers with Diabetes Have Altered Urinary Metabolic Profile at Birth. In Proceedings of the Neonatal Society 2012 Summer Meeting, Canterbury, UK, 21-22 June 2012.
12. Favretto, D.; Cosmi, E.; Ragazzi, E.; Visentin, S.; Tucci, M.; Fais, P.; Cecchetto, G.; Zanardo, V.; Viel, G.; Ferrara, S.D. Cord blood metabolomic profiling in intrauterine growth restriction. Anal. Bioanal. Chem. 2012, 402, 1109-1121. [CrossRef] [PubMed]
13. Dessì, A.; Marincola, F.C.; Fanos, V. Metabolomics and the great obstetrical syndromes-GDM, PET, and IUGR. Best Pract. Res. Clin. Obstet. Gynaecol. 2015, 2, 156-164. [CrossRef] [PubMed]
14. Taylor, S.N.; Basile, L.A.; Ebeling, M.; Wagner, C.L. Intestinal permeability in preterm infants by feeding type: Mother's milk versus formula. Breastfeed. Med. 2009, 4, 11-15. [CrossRef] [PubMed]
15. Alm, J.; Hagenfeldt, L.; Larsson, A. Concentrations of organic acids in the urine of healthy newborn children. Ann. Clin. Biochem. 1978, 15, 245-249. [CrossRef] [PubMed]
16. Gregersen, N.; Ingerslev, J.; Rasmussen, K. Low molecular weight organic acids in the urine of the newborn. Acta Paediatr. Scand. 1977, 66, 85-89. [CrossRef] [PubMed]
17. Ibarra, R.; Dazard, J.E.; Sandlers, Y.; Rehman, F.; Abbas, R.; Kombu, R.; Zhang, G.F.; Brunengraber, H.; Sanabria, J. Metabolomic analysis of liver tissue from the VX2 rabbit model of secondary liver tumors. HPB Surg. 2014, 2014, 310372. [CrossRef] [PubMed]
18. Gates, S.C.; Sweeley, C.C.; KrIvIt,W.; DeWitt, D.; Blaisdell, B.E. Automated metabolic profiling of organic acids in human urine. II. Analysis of urine samples from "healthy" adults, sick children, and children with neuroblastoma. Clin. Chem. 1978, 24, 1680-1689. [PubMed]
19. Marincola, F.C.; Dessì, A.; Corbu, S.; Reali, A.; Fanos, V. Clinical impact of human breast milk metabolomics. Clin. Chim. Acta 2015, 451, 28-34. [CrossRef] [PubMed]
20. Labbok, M.H. Effects of breastfeeding on the mother. Pediatr. Clin. N. Am. 2001, 48, 143-158. [CrossRef]
21. Friesen, R.W.; Novak, E.M.; Hasman, D.; Innis, S.M. Relationship of dimethylglycine, choline, and betaine with oxoproline in plasma of pregnant women and their newborn infants. J. Nutr. 2007, 137, 2641-2646. [PubMed]
22. Martin, R.M.; Gunnell, D.; Smith, G.D. Breastfeeding in infancy and blood pressure in later life: Systematic review and meta-analysis. Am. J. Epidemiol. 2005, 161, 15-26. [CrossRef] [PubMed]
23. L-oxoproline (pyroglutamic acid) during early life in term and preterm infants. Arch. Dis. Child. Fetal Neonatal Ed. 1997, 3, 152-157. [CrossRef]
24. Fanos, V.; Puddu, M.; Reali, A.; Atzei, A.; Zaffanello, M. Perinatal nutrient restriction reduces nephron endowment increasing renal morbidity in adulthood: A review. Early Hum. Dev. 2010, 86, 37-42. [CrossRef] [PubMed]
25. Dessì, A.; Ottonello, G.; Fanos, V. Physiopathology of intrauterine growth retardation: From classic data to metabolomics. J. Matern. Fetal Neonatal Med. 2012, 5, 13-18. [CrossRef] [PubMed]
26. Ju, H.; Chadha, Y.; Donovan, T.; O'Rourke, P. Fetal Macrosomia and pregnancy outcomes. J. Obstet. Gynaecol. 2009, 49, 504-509. [CrossRef] [PubMed]
27. Lawson, A.M.; Chalmers, R.A.;Watts, R.W. Urinary organic acids in man. I. Normal patterns. Clin. Chem. 1976, 22, 1283-1287. [PubMed]
28. D-ribose for type-2 diabetics. Prog. Biochem. Biophys. 2013, 40, 816-825. [CrossRef]
29. Fitzhardinge, P.M.; Steven, E.M. The small for date infant. II. Neurological and intellectual sequelae. Pediatrics 1972, 50, 50-57. [CrossRef] [PubMed]
30. Hadders-Agra, M.; Huisjes, H.J.; Touwen, B.C. Preterm or small for gestational age infants. Neurological and behavioural development at the age of 6 years. Eur. J. Pediatr. 1988, 147, 460-467. [CrossRef]
31. Barberini, L.; Noto, A.; Fattuoni, C.; Grapov, D.; Casanova, A.; Fenu, G.; Gaviano, M.; Carboni, R.; Ottonello, G.; Crisafulli, M.; et al. Urinary metabolomics (GC-MS) reveals that low and high birth weight infants share elevated inositol concentrations at birth. J. Matern. Fetal Neonatal Med. 2014, 2, 20-26. [CrossRef] [PubMed]
32. Dessì, A.; Marincola, F.C.; Pattumelli, M.G.; Ciccarelli, S.; Corbu, S.; Ossicini, C.; Fanos, V.; Agostino, R. Investigation of the ¹H-NMR based urine metabolomic profiles of IUGR, LGA and AGA newborns on the first day of life. J. Matern. Fetal Neonatal Med. 2014, 2, 13-19. [CrossRef] [PubMed]
33. Dessì, A.; Fanos, V. Myoinositol: A new marker of intrauterine growth restriction? J. Obstet. Gynaecol. 2013, 8, 776-780. [CrossRef] [PubMed]
34. Neuberger, A. The metabolism of glycine and serine. Comp. Biochem. 1981, 19, 257-303.
35. Gannon, M.C.; Nuttall, J.A.; Nuttall, F.Q. The metabolic response to ingested glycine. Am. J. Clin. Nutr. 2002, 6, 1302-1307.
36. O'Donovan, D.J.; Fernandes, C.J. Free radicals and diseases in premature infants. Antioxid. Redox Signal. 2004, 1, 169-176. [CrossRef] [PubMed]
37. Saugstad, O.D. Bronchopulmonary dysplasia-oxidative stress and antioxidants. Semin. Neonatol. 2003, 1, 39-49. [CrossRef]
38. Dani, C.; Cecchi, A.; Bertini, G. Role of oxidative stress as physiopathologic factor in the preterm infant. Minerva Pediatr. 2004, 4, 381-394.
39. Njålsson, R.; Norgren, S. Physiological and pathological aspects of GSH metabolism. Acta Paediatr. 2005, 2, 132-137. [CrossRef]
40. Jain, A.; Mehta, T.; Auld, P.A.; Rodrigues, J. Glutathione metabolism in newborns: Evidence for glutathione deficiency in plasma bronchoaveolar lavage fluid, and lymphocytes in prematures. Pediatr. Pulmonol. 1995, 20, 160-166. [CrossRef] [PubMed]
41. Mabrouk, G.M.; Jois, M.; Brosnan, J.T. Cell signalling and the hormonal stimulation of the hepatic glycine cleavage enzyme system by glucagon. Biochem. J. 1998, 330, 759-763. [CrossRef] [PubMed]
42. L-5-oxoproline kinetics and whole blood glutathione synthesis rates in severely burned adult humans. Am. J. Physiol. Endocrinol. Metab. 2002, 282, 247-258. [CrossRef] [PubMed]
43. L-oxoproline (pyroglutamic acid) is increased during recovery from severe childhood malnutrition and responds to supplemental glycine. J. Nutr. 1996, 126, 2823-2830. [PubMed]
44. Topp, H.; Fusch, G.; Schöch, G.; Fusch, C. Noninvasive markers of oxidative DNA stress, RNA degradation and protein degradation are differentially correlated with resting metabolic rate and energy intake in children and adolescents. Pediatr. Res. 2008, 64, 246-250. [CrossRef] [PubMed]
45. Dzúrik, R.; Spustová, V.; Lajdová, I. Inhibition of glucose utilization in isolated rat soleus muscle by pseudouridine: Implications for renal failure. Nephron 1993, 65, 108-110. [PubMed]
46. Eriksson, L.; Johansson, E.; Kettaneh-Wold, N.; Trygg, J.; Wikström, C.; Wold, S. Multi- and Megavariate Data Analysis; Umetrics Academy: Umeå, Sweden, 2013.